BERKELEY, Calif. (Business Wire EON) May 16, 2008 -- Dynavax Technologies Corporation (Nasdaq:DVAX) today reported primary endpoint data from a chamber study of TOLAMBA™ that showed a measurable clinical benefit, reducing total nasal symptom score (TNSS) by 41% vs. placebo

BERKELEY, Calif. (Business Wire EON) May 16, 2008 -- Dynavax Technologies (Nasdaq:DVAX) will webcast this morning a discussion of the TOLAMBA Chamber study data and provide an updated financial outlook for 2008. (PRWeb May 16, 2008) Read the full story

Canine and feline pancreatitis are disease targets for the Immune Selective Anti-Inflammatory Derivatives (ImSAIDs) from IMULAN BioTherapeutics. (PRWeb May 16, 2008) Read the full story at http://ww1.prweb.com/releases/2008/05/prweb945804.htm

www.Bloodpressuremedications.biz is an excellent site to obtain information regarding blood pressure medication and one can also purchase medicine online from the site. (PRWeb May 16, 2008) Read the full story at http://ww1.prweb.com/releases/2008/05/prweb945184.htm

Mindray Medical International has completed the acquisition of Datascope's patient monitoring device business.

ConvaTec has announced the availability of Versiva XC Gelling Foam Dressings with Hydrofiber Technology, in both adhesive and non-adhesive formulations, for use by health care professionals who treat acute and chronic wounds.

Ergonex Pharma has announced that the FDA has granted orphan drug designation to Terguride for the treatment of pulmonary arterial hypertension.

GlaxoSmithKline has reported new data from an extended follow-up study, which demonstrated Cervarix's ability in generating sustained high levels of neutralizing antibodies against the two most common cervical cancer-causing human papillomavirus types for up to 6.4 years.

Medison Pharma has announced that the Pharmaceutical Administration in Israel has approved Provigil for the treatment of idiopathic hypersomnia, sleep apnea and shift work disorder.

Japan based biopharmaceutical firm Sosei Group has announced its business restructuring plans.

Carticept Medical has announced that the first patients have been treated in a national, multi-center study of the company's Agilus therapy.

Bourne Capital Partners through its Canadian subsidiary, Critique Pharmaceuticals has announced the acquisition of Theramed, a full-service Canadian medical device, pharmaceutical and biotech commercialization company.

Sinobiomed has announced that it is launching the Phase II clinical trial of its patented malaria vaccine candidate, PfCP2.9, in epidemic areas in third quarter 2008.

Applied Nanoscience has received formal notification for the issuance of a patent in Singapore for its core technology platform encompassing filtering devices incorporating nanoparticles.

Critical Biologics has announced the successful enrollment of the first four patients in its 'first-in-man' clinical trial for Solinex, an intravenous formulation of recombinant human plasma gelsolin.

Adherex Technologies has signed a license agreement with the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, for the exclusive use of data from a Phase III trial conducted by Charlotte Zuur and her colleagues with sodium thiosulfate to prevent

Salix Pharmaceuticals has announced that Salix Pharmaceuticals, Norgine, and Norgine Europe, have filed a lawsuit in the US District Court of New Jersey against Novel Laboratories, for infringement of Norgine's patent protecting Moviprep.

Masimo has received the FDA clearance for its breakthrough noninvasive and continuous total hemoglobin monitoring technology.

Pozen has notified the FDA that ownership of the investigational new drug application and new drug application for Treximet has been officially transferred to GlaxoSmithKline.

SynCo Bio Partners, a GMP biopharmaceutical manufacturer, has completed the manufacture and release of ActoGeniX's drug substance AG011 for use in a Phase II clinical trial with ulcerative colitis patients.